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ABSTRACT 
The muscular dystrophies (MD) are a group of genetic diseases characterized by progressive weakness and 
degeneration of the skeletal muscles that control movement. DMD is one among the most common muscular 
disorders. The incidence is 1:3500 live male birth. It is X-linked recessive disease caused by a deficiency of a 
normal muscle protein called dystrophin, which maintains the integrity of the muscle cell wall. Degeneration of 
the skeletal muscles, which control movement leading to lose the ability to stand, walk and loss of ambulation 
before 10 years, with progression of the disease most patients succumb to death in their early 20s.Disease is 
having bad prognosis if the treatment start in early stages of the disease, it may slow or stop the progressive 
degeneration of muscles. As there is no specific treatment in any system of medicine for DMD, in modern 
therapeutic approach of muscular dystrophy is represents on corticosteroids, physical therapy, respiration 
assistance and gene therapy. All major neuromuscular disorders are identified with Vata dosha. In Ayurveda 
this pathogenesis can be clearly understood by the concept of Adi bala pravritta vyadhi. Here the pathogenesis 
occurs due to the Beejabhagavayava Dushti which leads to Mamsa Vata Dushti. The Ayurvedic treatments 
relevant to Rasayana group of herbo-mineral medicines and specified Panchakarma therapies have definite 
protective influence and long survival on Dhatu Kshaya. Keep upon this view in present study the therapies 
and medicines is useful for DMD is taken with their logical understanding.  
 KEYWORDS: Duchenne muscular dystrophy, Dystrophin, Beeja Dushti, Mamsa-Vata Kshaya, Agni, 
Srotoshodhan. 
INTRODUCTION
The word dystrophy comes from Latin and Greek 
roots meaning of faulty nutrition. The disease was first 
described by Neapolitan physician Giovanni Semmola in 
1834 and Gaetano Conte in 1836.However DMD was 
named by French neurologist Guillaume-Benjamin-Amend 
Duchene in 1806-1875[1]. Dystrophinopathies are a group 
of disorders resulting from mutations in the dystrophin 
gene located on the short arm of X chromosome in the 
Xp21 region. Duchenne muscular dystrophy is the most 
common dystrophinopathy. Duchene muscular dystrophy 
is known as x-linked recessive disorder. It affects muscles 
and lead weakness of muscular strength and function of 
muscles. This syndrome is marked by either generalized or 
localized. In DMD involve mutations in the dystrophin 
gene [2] Dystrophin is cytoskeletal protein localized in the 
inner surface of the muscle membrane and it forms 
dystroglycal-glycoprotein complex.[2]. This complex helps 
to maintain the integrity of muscle cells. So absence of 
dystrophin results in the destabilization of the entire 
dystroglycan-glycoprotein complex. So muscle mass is not 
growth well and cause to weakness of muscles. This 
condition is most apparent or symptomatic in skeletal 
muscle only heart and diaphragm muscle often involved. 
Most patients die because of heart failure or respiratory 
problems. An incidence of 1 in 3500 live male births. Each 
child of a carrier mother has a 50% chance of DMD. 
Though girls can be carrier, more than 80% shows no DMD 
related syndrome. Diagnosis of these disorders is based on 
clinical presentation, genetic testing, Muscle biopsy and 
muscle imaging. No any treatment is at present in DMD 
definitely in any medical field. Therapeutic approach of 
muscular dystrophy is represents on corticosteroids, 
physical therapy, respiration assistance and gene therapy. 
Genetic Appraisal 
Over 4700 mutatios have been reported in the 
leiden Duchenne muscular dystrophy mutation database. 
Deletion of >1 exons is the most common mutation seen. In 
dystrophinopathies, 65%of the pathogenic changes are 
large partial deletions. Mutations in the dystrophin gene 
can cause Duchenne muscular dystrophy or Becker 
muscular dystrophy. This is explained by the reading 
frame hypothesis, which states that mutations that disrupt 
the reading frame eventually leads to dystrophin 
deficiency and usually cause Duchenne muscular 
dystrophy.[3] 
Pathogenesis 
Dystrophy is a genetic defect and is caused by lack 
of a single muscle protein Dystrophin. DMD and BMD are 
due to different changes in the dystrophin gene, which 
contains information for a protein that is important for 
muscle cells to work properly. This gene is located on the X 
chromosome. Dystrophin is localized to the sarcolemma in 
normal skeletal muscle, but is completely absent in muscle 
from DMD patients.[4] At present a hypothesis postulates a 
defect in the sarcolemma membrane which allows a 
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substance as yet unknown but which could possibly be 
calcium, to enter the muscle fiber too freely, and there to 
activate neutral proteases which in turn maintain an 
excessive degree of muscle catabolism and lead to muscle 
fiber necrosis.[5, 6, 7, 8] 
Clinical Features 
Children with Duchenne muscular dystrophy 
usually become symptomatic before age of 5 yr and may 
even have history of delayed walking. Gait disturbances 
often become apparent at 3-4 yr of age. Waddling gait, 
Gower sign, and calf muscle pseudo hypertrophy are 
classical findings at this stage. Neck flexor muscle 
weakness is early. The progression of weakness may 
plateau between 3 and 6 yr of age. Subsequently there is 
increasing gait difficulty, development of contractures and 
increased lumber lordosis. Natural history studies have 
shown the age at loss of independent ambulation in 
untreated Duchenne muscular dystrophy to be between 
8.8 and 10.5 yr. After loss of ambulation, there is 
worsening kyphoscoliosis, increasing upper limb 
weakness and bulbar dysfunction. 
 Weakness of intercostals and diaphragmatic 
muscles with spinal deformity affects the respiratory 
function. Dropping of vital capacity <20% of normal leads 
to nocturnal hypoventilation. Cardiomyopathy and 
arrhythmias are the major cardiac manifestations in 
Duchenne muscular dystrophy. Children with deletions of 
exons 48 to 53 are especially prone for cardiac 
complications. The cause of death in Duchenne muscular 
dystrophy patients is usually a combination of respiratory 
insufficiency and cardiomyopathy. Other clinical features 
of Duchenne muscular dystrophy include variable degree 
of intellectual disability and impaired gastric motility. 
 Around 10% of female carriers may show 
variable, degree of weakness with elevated creatine kinase 
levels, calf hypertrophy, cramps and increased risk of 
dilated cardiomyopathy. Full Duchenne muscular 
dystrophy phenotype may be present in case of complete 
inactivation of normal X chromosome. 
Muscles Feature 
 Hypertrophy of calf muscles is striking feature, 
Calf, Glutei, deltoid, brachio-radialis and tongue muscles 
may appear large, Sternal head of pectoralis major and 
supraspinatous are atrophied  
Laboratory Findings 
 The Serum creatine kinase levels are generally 
elevated. It has no correlation with severity of the disease 
or response to treatment. Multiplex PCR and the more 
sensitive multiplex ligation-dependent probe amplification 
are commonly employed genetic techniques for detection 
of mutations. Muscle biopsy may be required in mutation 
negative cases and also to differentiate between these two 
dystrophinopathies. The muscle biopsy shows features of 
muscular dystrophy which include necrosis and attempted 
regeneration of individual muscle fibers, increased 
variability of muscle fiber diameter with both 
hypertrophic and small fibers, and central nuclei. In end 
stage biopsy, almost the entire muscle is replaced by fibro 
fatty tissue. To confirm the clinical diagnosis immune histo 
chemical analysis of the muscle biopsy is usually 
performed. Absence of dystrophin stating is seen in 
Duchenne muscular dystrophy.  
Diagnosis 
Damaged muscles release enzymes such as 
Creatine Kinase (CK) into the blood. High blood levels of 
CK suggest a muscle dystrophy.  
Electromyography: Changes in the pattern of electrical 
activity can confirm a muscle disease.  
Muscles Biopsy 
The analysis distinguishes muscular dystrophies 
from other muscle diseases. Special tests can identify 
Dystrophin and other markers associated with specific 
forms of muscular dystrophy. 
Complications 
 Respiratory muscle involvement and respiratory failure 
 Pharyngeal weakness  
 Contractures 
 Scoliosis and thoracic deformities 
 Cardiomyopathy leading to CCF 
 Intellectual impairment 
 Learning disabilities 
Table 1: Differences from Becker Dystrophy 
 Duchenne Dystrophy Becker Dystrophy 
Agetill ambulatory  10-12 years Late adolescence or early adult life 
Learning disabilities common less frequent 
Onset of weakness  Earlier  Later 
Death By 18 years 25-40 years[9] 
MANAGEMENT
There is currently no cure for any form of 
muscular dystrophy in modern medical science 
Treatment is only helps in prevention or reduction in 
deformities. 
monitoring 
Pulmonary function tests-every 6 months if non –
ambulatory, annually in ambulatory patients 
Echocardiography: once in 2yr for<10 yr of age, annually 
if>10 yr 
Serum calcium, phosphate annually 
 
 
Physical therapy 
Effective stretching and appropriate positioning at various 
joints, assistive devices to prevent contractures, avoid high 
resistance strength training, surgery for fixed contractures 
and spinal deformities 
Other components 
Respiratory and cardiac care 
Management of gastrointestinal problems 
Psychosocial management 
Family education and genetic counselling 
Newer therapies 
Exon skipping, gene therapy, cell therapy 
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 Management of a child with Duchenne muscular 
dystrophy requires a multidisciplinary team. The 
mainstays of management are maintenance of strength 
and joint range of motion by exercise, physiotherapy and 
avoidance of prolonged immobility. Corticosteroids are the 
only therapies proven to improve strength and prolong 
ambulation in children with DMD. Other supportive 
management includes pulmonary and cardiac care, 
nutrition, calcium homeostasis, appropriate immunization 
and orthopaedic care. 
Ayurvedic Parlance 
Body is originally composed of Doshas, Dhatus and 
Malas.[10] in normal status of Doshas etc. They should be 
preserved in all ways by the method as prescribed in the 
code of healthy living. [11].Pathogenic factors in the body 
are Vayu, Pitta and Kapha, while those in the mind are 
Rajas and Tamas. Vata occupies the most prominent place 
among the pathogenic factors in the body. Its prominence 
is due to the acuteness, varieties and seriousness of 
disease caused by it. [12] The Vata in its normal state of 
functions sustains all the organs of the body. It prompts all 
types of actions. It brings about compactness in all the 
tissue elements of the body.[13] Vata when aggravated 
afflicts the body with various types of disease and affects 
the strength, complexion, happiness and the span of life.[14] 
Aggravation of Vayu gives rise of contraction, stiffness of 
joints and pain in the bones as well as joints, atrophy of 
limbs and insomnia.[15] The function of Sleshma is to build 
fresh tissues (Brimhana), to increase its strength 
(Balakrita) and to give firmness to the limbs (Sthairya 
krita). [16] Rasa provides contentment and saturation and 
nourishes blood, blood generates clarity in complexion, 
nourishes muscles and sustains life, Muscle strengthens 
the body and nourishes Medas. Mamsa Dhatu is 
responsible for movements like extension, flexion, upward 
and downward movement (Su.Ni.1/17-18), make Sharira 
Pushti - Strengthen the body (S.Su.15), Medas Pushti - 
Uttardhatu Poshana an also Ojokar – promote immunity 
and resistance. In decrease of muscles, wasting of buttocks, 
cheeks, lips, pubic region, thigh, chest, axilla, calf abdomen 
and neck, roughness, piercing pain, malaise and looseness 
of arteries.[17] These all are the normal and abnormal 
function of the Doshas and Dhatus. 
Factors Responsible for Abnormality in Foetus 
Because of the defects in seeds (Sperm, Ovum), 
actions associated with the Soul, uterus, time and food as 
well as regimen of the mother, Doshas get variously 
vitiated and this results in the impairment of the shape, 
colour and sensory as well as motor organs of the 
offspring. So the foetus in the uterus of the mother gets 
afflicted with the vitiated Doshas [18] 
Factors for Hereditary Defects 
 As a matter of fact, the sense organs of all living 
beings are born out of the soul and their existence or 
otherwise is determined by the fate i.e. the result of the 
past action. So the offspring of the dull parents do not 
invariably resemble their parents. [19] 
  DMD cannot be directly co-related with any single 
disease in Ayurveda. All most all major neuromuscular 
disorders are identified with Vata Dosha. This disorder can 
be considered under Vata vikar due to Beeja Dushti 
because of Adibalapravritta. [20] The important causative 
factors can be brought under Aatma Karmaja and Beeja 
Dosha.[21] These factors bring Khavaigunya at Mamsa 
Dhatu levels leading to vitiation of Vata which causes 
Bhutagni impairment. [22] Thus these causes attribute to 
DMD may be analysed as Beeja Dusti and Atma Karma are 
responsible for the X-linked recessive disease as well as 
gene mutations. 
Samprapti Ghataka  
The principal factors involved  
Dosha: Vata and Kapha     
Dushya: Mamsa  
Srotasa: Mamsavaha  
Srotodushti: Sang   
Agni: Mamsa-Dhatvagni  
Samprapti  
Samprapti may take place under Srotorodha, Beej Dushti 
and Agni. Ayurvedic Acharyas carefully consider this 
condition as Adibala-Pravrit Mamsa Vata Kshaya due to 
Srotorodha. There is depletion of Mamsagni paving the 
way of Ama formation. It is followed by Vitiation of Kapha 
Dosha. [23, 24, 25] while Srotorodha produces hypertrophy in 
particular region, it also manifests as first Prakopa then 
depletion of Vata aliment. This complex pathogenesis is 
responsible for progressive wasting and necrosis of the 
affected muscle fibers. 
Also Samprapti can be sort out as it is result of 
Mamsa-Vata Kshaya due to Beeja Dosha which leads to 
Vata Vaishamya of Mamsa Dhatu. This Vitiated Vayu causes 
improper formation of Mamsa Dhatu by its influence on 
the Dhatvagni of Mamsa.[26] So depletion of Mamsagni 
causes formation of Ama which leads to faulty nutrition 
and causes progressive relentless degeneration of muscle 
tissue.[27][65] 
Dhatus are those substances which are retained by 
the body and always rejuvenated or replenished Ras-
Raktadi seven Dhatus which develops in human body in a 
fixed sequential manner one from the other. Each 
succeeding Dhatu is a metabolic refinement of the previous 
Dhatu and get nourished by it. The first Dhatu, Rasa is the 
metabolic end product of the digestion that takes place 
within gastro-intestinal tract. Rasa Dhatu has to 
metabolized in to Rakta Dhatu. The Mamsa Dhatu comes 
from Rakta Dhatu and in turn give rise to Meda Dhatu. The 
Asthi Dhatu is the product of Meda Dhatu Paka that 
contains Majja Dhatu which is the prime seat of Vata 
element.[23,25] If the circulating Rasa of Mother is 
undernourished or defective, the development of Mamsa 
Dhatu is affected. Agnis are responsible for the process of 
metabolism. Each of seven Dhatus has individual 
Dhatvagnis. The increase or decrease of a particular Dhatus 
depends upon the increase or decrease of respective 
Dhatvagnis. According to Charak, Mamsa Kshaya may be 
present when there is prolonged Majjagata Kupit Vata. 
This is always followed by depletion of Vata element. It is 
genetic predisposition(Beejadosha) that convert 
physiological Vata element in to pathological morbidity. 
The Srotodushti is responsible for the Mamsa Dhatu 
Kshaya. 
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Management  
Acharyas while explaining the Dhatupaka Avastha 
clearly signifies the importance of Agni which is whole and 
sole responsible for the formation of next Dhatus. Thus 
correction of Agni should be done by administration of 
Deepan and Pachan Dravyas in order to strengthen the 
process, Doshas must be balanced and metabolic toxins 
must be eliminated from Dhatus through Panchakarma. 
[28].The pre operative process quoted by Acharyas has the 
concept of “Bruhmanyastu Mrudu Langyet” that signifies 
the usage of Rukshana for better Brimhana treatment 
modalities.[29] For example Udvatrana with Kola-Kulattha 
which helps in the removal of Srotorodha and does Sthiri 
Karan of Angas. Pachana medicines are also explained as a 
mode of Rukshana Chikitsa and it is also must in the 
treatment of DMD initially with Deepana like Parisheka 
with Dhanyamla.[30, 31] 
There is no any other excellent treatment for Vata 
Dushti such as Basti Therapy[32] Niruha Basti is the 
superlative therapy in Pancha karma field and it has a 
pivotal ability to re-construct of damaged muscles or 
nerves.[33] RajYapan Basti does priority which are 
supplying proper tone to the muscles and promoting the 
blood circulation with both Shodhana and Brumhana 
properties of its own as well as very much beneficial which 
pacifies the provoked Vata Dosha, increased strength of 
the person, maintains health and longevity.[34] Rajyapan 
Basti is having Sadhyo Balajanana and Rasayan properties 
means, it increase the power of the body and promotes 
strength of the body quickly.[35] By this Sadhyo Balajanana 
and Vatashamak properties of Rajayapan Basti, normalize 
and enhance the action of Udan Vata even enriched the 
Rasa Dhatu. Deepana, Pachana properties of Basti help to 
kindling of Agni[36]. Agni is very essentials for the 
formation of Dhatus and process of metabolic 
transformation[37]. Rajyapan Basti can be given for a long 
time period. Colonic mucosa transport irons, small 
molecules and water through the colonic membrane back 
and forth between lumen and plasma as a systemic effect. 
So it can get absorbed Rasayana effects without involving 
of drugs metabolism which occurs in stomach. So directly 
and quickly body get effect of whole drugs. So body 
nourished quickly and longer time duration without any 
complication.[38] Besides colon is enriched mucosal 
immune system. So immune system is even enhancing by 
the cleansing of colon. Drug can properly reach up to cell 
level due to removal of Srotorodha and helps to correction 
of Mamsagata Dushti. According to Sushruta there is better 
absorption occurs in Rasayana drugs after the elimination 
process. So body will quickly get Brimhana.[39] 
Enteric nervous system is immensely complex of 
neurons and present in the wall of gastrointestinal tract. 
This system mediates directly to regulate the intestinal 
blood supply and mucosal epithelial water and electrolytes 
transport[40]. Due to Sadhyo Balajanan and Rasayan effect 
of Basti, the immensely number of nerves which located in 
ENS can get nourished directly. So can be supposed in 
DMD muscle weakness is getting decreased and muscles 
gets proper nourishment daily by given Rajyapan Basti. 
Due to Madhura, Guru and Jeevaneeya properties 
of milk gives Rasayana, Vrishya, Balya, Medhya and 
Brimhana benefits[41]. Due to Yogvahi, Rasayana and 
Tridoshahara properties of Honey helps to nourished the 
muscles and scraps adhered Doshas from Srotas. Paste help 
to increase the functions of Brimhana and Balya upon the 
properties which they have and also give required 
thickness to the Basti material. So Basti may be retained in 
Pakvashaya for appropriate time. Due to Sukshma property 
of rock salt it reaches up to the micro channel of the body. 
Due to its Tikshna property it helps to break down the 
morbid materials and Dosha Sanghatan[42]. Sodium iron 
fulfils essential action during absorption process by Basti. 
By the adding of Ghee enhances Varna, Bala, Rasa, Shukra 
and Ojas in DMD due to the properties of Madhura Rasa, 
Sheeta Veerya and Vatapittahara properties[43] Rajyapan 
Basti drugs also enriched with Tikta Rasa dominance such 
as Daruharidra (Berberis aristata DC), Guduchi (Tinospora 
cordifolia (thumb) etc. In one study on spinal cord injury 
had been proved stem cells implantation due to Curcumin 
(Diferuloylmethane) which is the active ingredient of 
Turmeric (Curcuma longa L)[44].Turmeric is a Tikta Rasa 
(Bitter test) dominant plant. There by it may have positive 
impact on cell implantation by Tikta Rasa dominance and 
Tikta Ras helps to reduce the degeneration of Asthi and 
Majja. It resultant to decrease of muscle wasting.[44, 45] By 
all these impacts which are adding to the Rajyapan Basti 
given logical and beneficial effect in the DMD to enrich 
their weakened muscles.[67] 
Research has shown that Virechana does the 
detoxification which lead to better absorption of Rasyana 
Drugs, other Brihmana Dravyas and correction of Agni.[46] 
Matra Basti is another variety of the Karma. It also 
rejuvenates the body and further helps in improving from 
the Dhatukshaya caused due to Vata Dosha that is why 
both Virechana and Basti are explained in the principle of 
Medomamsa Dushti.[47]  
Not only these invasive therapies like Virechana, 
Basti etc. but Upkarma i.e., Para Panchakarma procedures 
are very much essential for the same. It is very well 
understood in the treatment principle of Vata Roga by 
Charaka and Yogaratnakar that Upakarmas like Swedana is 
having prime treatment modalities.[48] Abhyantra Snehana 
helps to pacifies the Vata Dosha. [49] Whereas Swedana like 
Shastika Shaali Pinda Swedana also improves the tone of 
the body.[50] Swedana Karma increases the metabolic 
activity which in turn increases the oxygen demand and 
blood flow. This vasodilatation stimulates the superficial 
nerve ending causing a reflex dilatation of the arterioles. 
Due to the effect of heat on the sensory nerve ending there 
will be a reflex stimulation of sweat glands in the areas 
exposed to heat. This rise in temperature induces muscle 
relaxation and increases the efficacy of muscle action as 
the increased blood supply ensures the optimum condition 
for the muscle contraction.[51] Swedana also acts by the 
mechanism of thermoregulation regulated by skin and 
coordinated with the functions of the other excretory 
organs. It is supplied with many groups of nerves, which 
conduct various stimuli. The secretion of sweat is under 
nervous system control, especially autonomous. The hair 
of the skin is tactile sense organs and their secretion 
produces some nervous changes. Thus, Swedana can bring 
about changes indirectly on the autonomic nervous system 
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and the heat can bring about changes in conduction of 
nerve stimuli, by changing sodium-ion concentration.[52] 
Thus these modalities are of prime importance as no 
treatment acts on prime pathogenesis and present 
approach is taken to improve quality of life over muscular 
dystrophy.[66] 
Vata and Rakta Dhatu are two major life 
sustaining elements in the body. The Vata has been 
attributed like genetic material that carriers life 
information essential for different activities. The Rakta 
Dhatu is the basis of biological force that provides 
nutrition at cellular level and paves the way of excretion of 
metabolic toxins. The driving force beyond Rakta Dhatu is 
Vata element which circulates itself to cellular level along 
with Rakta. The conjoint circulation of both Rakta and Vata 
is manifestation of life (Prana). This Prana is responsible 
for the contraction and relaxation of muscle fibers or 
muscular activity. It means we have to focus our attention 
on the Dhatvagnis Paka of Rasa-Rakta-Mamsa-Medo 
Dhatus. In this context Ayurvedic Rasayana Therapy has 
significant role to play[53,54] Ancient Ayurvedic physicians 
had developed certain dietary and therapeutic measures to 
delay degeneration process and rejuvenating whole 
functional dynamics of the body system. This revitalization 
and rejuvenation is known as the Rasayan Chikitsa. 
Rasayana are special Ayurvedic resources that increase 
enzymatic essence of each Dhatu starting from Rasa Dhatu. 
Ayurveda uses herbal mineral and metallic source for this 
purpose. The pure gold Bhasma in law dose has been used 
successfully in the management of degenerative disease of 
Mamsa and Majja Dhatu.[55,56,57] Certain Ayurvedic herbs 
known for their Rasayana effects are being scientifically 
verified for their possible effect in the Management of 
Muscular Dystrophy. The well known herb Curcuma longa 
has been widely investigated for the immune-localized and 
activation of nuclear factor-{Kappa}B in polymyosities, 
dermatomyositis and DMD. Withania somnifera is used for 
stamina and brain functions. It contains Withanolide which 
is anti –inflammatory, induces significant regeneration of 
axons, pre-synapses and post –synapses in the neurons. It 
suppress free radical generation, It also ameliorates 
neuronal dysfunction.[58,59,60] The cardiac problems 
associated with some forms of muscular dystrophy 
sometimes need treatment. Terminalia Arjuna has 
remarkable cardio protective, heart muscle strengthening 
properties. Regular use of Arjuna improves pumping 
activity of heart, improves cardiac muscle strength. 
Tinospora cordifolia have been used in general debility. It 
is also an effective immunostimulant. It is used in 
Ayurvedic Rasayana to improve the immune system and 
the body’s resistance to infections.[61] 
 Usually Rasayana molecule does not work 
without purificatory procedures. After the purification 
Rasyana therapy can be adopted. The Deepana, Pachana 
process must be strengthened the Dosha must be balanced 
and metabolic toxins must be eliminated from Dhatu 
through Panch karma procedures in order for Rasayana 
molecule to work.[62,63] Yogic support is always found 
useful in the management of Muscular Dystrophy. 
Pavanmuktasana series of Yoga Asanas and Bhastrica 
Pranayama are important, especially when the dystrophy 
has progressed for several years. Deep breathing and 
laughing is often recommended to optimize respiratory 
care.[55, 56] 
Ayurvedic management did not claim for the 
genetic effect of restoring dystrophin production, it did 
reduce serum CK levels. This could be a sign of decreased 
muscle damage. Since there was definite improvement in 
functional ability, it is possible that complementary 
Ayurvedic treatment allow longer survival with minimum 
disability. 
CONCLUSION 
 Beej Dushti, Agni, Srotorodh are responsible 
for the disease. Ama Pahan, Agnidipan Drugs, Anti Visha 
Dugs, Psychotropic Drugs Brimhana Drugs Rasayan Drugs, 
Sroto Shodhak Drugs are beneficial for the treatment. 
Shodhan purpose Udvartana with Kola-Kulattha Churna, 
Shashtik Shali Pinda Sweda and Yapan Basti are beneficial. 
Treatment is only helps in prevention or reduction in 
deformities. “By the Ayurvedic treatment We cannot add 
year into the life but we can add quality in life”.  
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